Pacira Biosciences
PCRX
#5836
Rank
NZ$1.86 B
Marketcap
NZ$41.53
Share price
0.04%
Change (1 day)
25.83%
Change (1 year)
Categories

Pacira Biosciences (PCRX) - Cash on Hand

Cash on Hand as of September 2025 : NZ$0.42 Billion

According to Pacira Biosciences 's latest financial reports the company has NZ$0.42 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Pacira Biosciences - Cash on Hand chart (from 2009 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31NZ$0.85 B95.07%
2023-12-31NZ$0.44 B-3.11%
2022-12-31NZ$0.45 B-52.69%
2021-12-31NZ$0.96 B32.92%
2020-12-31NZ$0.72 B66.78%
2019-12-31NZ$0.43 B-24.17%
2018-12-31NZ$0.57 B30.4%
2017-12-31NZ$0.43 B75.94%
2016-12-31NZ$0.24 B7.28%
2015-12-31NZ$0.23 B16.17%
2014-12-31NZ$0.19 B127.72%
2013-12-31NZ$87.8 M75.95%
2012-12-31NZ$49.9 M-48.86%
2011-12-31NZ$97.57 M188.06%
2010-12-31NZ$33.87 M247.65%
2009-12-31NZ$9.74 M-54.35%
2008-12-31NZ$21.34 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Recro Pharma
REPH
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Flexion Therapeutics
FLXN
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Cara Therapeutics
CARA
NZ$65.61 M-84.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Heron Therapeutics
HRTX
NZ$96.04 M-77.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Omeros Corporation
OMER
NZ$49.75 M-88.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Zogenix
ZGNX
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA